Homoeopathic treatment of allergic runny nose and sneezing

Double-blind, randomized, placebo-controlled, pilot trial of individualized homoeopathic medicines in perennial allergic rhinitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028623

Enrollment

Registered

2020-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies, as decided appropriate

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition depending upon the individual requirement of the cases. Route of administration: oral. Each patients will be given general advices on saline steam inhalations and acute homoeopat

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years and of either sex 2. Cases suffering from allergic rhinitis (2020 ICD-10-CM Diagnosis Code J30.89) ? persistent and perennial variety and of moderate intensity for more than 1 year 3. Atopic: reactive to inhaled allergens 4. Literate patients; can read Bengali and/or English 5. Providing written informed consent to participate in the trial

Exclusion criteria

Exclusion criteria: 1. Nasal abnormalities causing obstruction; e.g. nasal polyps, deviated septum 2. Allergen avoidance in past 6 weeks 3. Away from usual environment for more than 1 week during trial 4. Respiratory infections 5. Patients with risk of developing bronchial asthma 6. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life 7. Patients who are too sick for consultation 8. Pregnant and puerperal women, and lactating mothers 9. Substance abuse and/or dependence 10. Self-reported immune-compromised state 11. Oral or parenteral steroids in past 6 months 12. Conventional desensitization in past 6 months 13. Previous homoeopathic immunotherapy for perennial AR 14. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

Measure	Time frame
Juniper Rhino-conjunctivitis Quality of Life Questionnaire (RQLQ)Timepoint: At baseline and after 3 months	—

Secondary

Measure	Time frame
Visual analogue scale (VAS) measures of nasal, non-nasal and global severity and quality of life (QoL)Timepoint: At baseline and after 3 months	—

Countries

India

Contacts

Public ContactProf Dr Rajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026